364 related articles for article (PubMed ID: 12124336)
1. Interleukin 2 gene transfer prevents NKG2D suppression and enhances antitumor efficacy in combination with cisplatin for head and neck squamous cell cancer.
Li D; Ronson B; Guo M; Liu S; Bishop JS; Van Echo DA; O'Malley BW
Cancer Res; 2002 Jul; 62(14):4023-8. PubMed ID: 12124336
[TBL] [Abstract][Full Text] [Related]
2. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
O'Malley BW; Li D; McQuone SJ; Ralston R
Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
[TBL] [Abstract][Full Text] [Related]
3. [IL-2 gene and cisplatin combined therapy for head and neck squamous cell carcinoma].
Liu S; Lin Y; Tang S; Yang H; Liang C
Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Jun; 19(3):191-3. PubMed ID: 12539412
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-21 triggers both cellular and humoral immune responses leading to therapeutic antitumor effects against head and neck squamous cell carcinoma.
Nakano H; Kishida T; Asada H; Shin-Ya M; Shinomiya T; Imanishi J; Shimada T; Nakai S; Takeuchi M; Hisa Y; Mazda O
J Gene Med; 2006 Jan; 8(1):90-9. PubMed ID: 16097036
[TBL] [Abstract][Full Text] [Related]
5. Combination nonviral cytokine gene therapy for head and neck cancer.
Li D; Zeiders JW; Liu S; Guo M; Xu Y; Bishop JS; O'Malley BW
Laryngoscope; 2001 May; 111(5):815-20. PubMed ID: 11368072
[TBL] [Abstract][Full Text] [Related]
6. Combined IL-2 and IL-12 gene therapy for murine head and neck squamous cell carcinoma.
Liu S; Yang H; Liang C
Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):323-6. PubMed ID: 12408755
[TBL] [Abstract][Full Text] [Related]
7. Combination nonviral interleukin 2 gene therapy and external-beam radiation therapy for head and neck cancer.
Bray D; Yu SZ; Koprowski H; Rhee J; Kumar S; Pericle F; Suntharalingam M; Van Echo DA; Li D; O'Malley BW
Arch Otolaryngol Head Neck Surg; 2003 Jun; 129(6):618-22. PubMed ID: 12810463
[TBL] [Abstract][Full Text] [Related]
8. Combination surgery and nonviral interleukin 2 gene therapy for head and neck cancer.
Li D; Jiang W; Bishop JS; Ralston R; O'Malley BW
Clin Cancer Res; 1999 Jun; 5(6):1551-6. PubMed ID: 10389944
[TBL] [Abstract][Full Text] [Related]
9. [Combined interleukin-2 and herpes simplex virus thymidine kinase gene therapy for head and neck squamous cell carcinoma].
Liu S; Liang C; Yang H; Xian J
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Dec; 36(6):426-9. PubMed ID: 12761956
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-28B acts synergistically with cisplatin to suppress the growth of head and neck squamous cell carcinoma.
Yoshimoto K; Kishida T; Nakano H; Matsui M; Shin-Ya M; Shimada T; Nakai S; Imanishi J; Takeuchi M; Hisa Y; Mazda O
J Immunother; 2011 Mar; 34(2):139-48. PubMed ID: 21304406
[TBL] [Abstract][Full Text] [Related]
11. Combination nonviral murine interleukin 2 and interleukin 12 gene therapy and radiotherapy for head and neck squamous cell carcinoma.
Xian J; Yang H; Lin Y; Liu S
Arch Otolaryngol Head Neck Surg; 2005 Dec; 131(12):1079-85. PubMed ID: 16365221
[TBL] [Abstract][Full Text] [Related]
12. [Combination radiation and gene therapy for head and neck squamous cell carcinoma in the murine model].
Liu SX; Yang H; Yuan YM; Guo YF; Tang ZQ; Liang CY
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 May; 39(5):278-82. PubMed ID: 15338865
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte-macrophage colony-stimulating factor in a combination gene therapy strategy for head and neck cancer.
Day KV; Li D; Liu S; Guo M; O'Malley BW
Laryngoscope; 2001 May; 111(5):801-6. PubMed ID: 11368071
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-27 activates natural killer cells and suppresses NK-resistant head and neck squamous cell carcinoma through inducing antibody-dependent cellular cytotoxicity.
Matsui M; Kishida T; Nakano H; Yoshimoto K; Shin-Ya M; Shimada T; Nakai S; Imanishi J; Yoshimoto T; Hisa Y; Mazda O
Cancer Res; 2009 Mar; 69(6):2523-30. PubMed ID: 19244121
[TBL] [Abstract][Full Text] [Related]
15. Antitumor and antiangiogenic effects of interleukin 12 gene therapy in murine head and neck carcinoma model.
Imagawa Y; Satake K; Kato Y; Tahara H; Tsukuda M
Auris Nasus Larynx; 2004 Sep; 31(3):239-45. PubMed ID: 15364358
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effects of cytolytic T lymphocytes (CTL) and natural killer (NK) cells in head and neck cancer.
Whiteside TL; Chikamatsu K; Nagashima S; Okada K
Anticancer Res; 1996; 16(4C):2357-64. PubMed ID: 8816835
[TBL] [Abstract][Full Text] [Related]
17. E10A, an adenovirus-carrying endostatin gene, dramatically increased the tumor drug concentration of metronomic chemotherapy with low-dose cisplatin in a xenograft mouse model for head and neck squamous-cell carcinoma.
Adhim Z; Lin X; Huang W; Morishita N; Nakamura T; Yasui H; Otsuki N; Shigemura K; Fujisawa M; Nibu K; Shirakawa T
Cancer Gene Ther; 2012 Feb; 19(2):144-52. PubMed ID: 22116375
[TBL] [Abstract][Full Text] [Related]
18. [Studies of mouse interleukin-2 gene therapy for head, and neck sequamous cell carcinoma using polycationic liposome-mediated transduction].
Yang H; Liu S; Liang C; Peng W
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jan; 34(1):9-11, 30. PubMed ID: 15600166
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2.
Nagashima S; Reichert TE; Kashii Y; Suminami Y; Chikamatsu K; Whiteside TL
Cancer Gene Ther; 1997; 4(6):366-76. PubMed ID: 9408607
[TBL] [Abstract][Full Text] [Related]
20. Antisense cyclin D1 enhances sensitivity of head and neck cancer cells to cisplatin.
Wang MB; Yip HT; Srivatsan ES
Laryngoscope; 2001 Jun; 111(6):982-8. PubMed ID: 11404608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]